# IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia

> **NCT00524342** · PHASE2 · COMPLETED · sponsor: **Margaret Ragni** · enrollment: 7 (actual)

## Conditions studied

- Von Willebrand Disease

## Interventions

- **DRUG:** Oprelvekin, Interleukin 11, IL-11

## Key facts

- **NCT ID:** NCT00524342
- **Lead sponsor:** Margaret Ragni
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524342, "IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00524342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*